A PHARMACEUTICAL COMPOSITION CONTAINING BENZNIDAZOLE AND AMPHOTHERICIN BN-(L)-HISTIDINAMIDE FOR THE TREATMENT OF TRYPANOSOMIASIS

The present invention relates to a pharmaceutical composition for treating trypanosomiasis or infections caused by Trypanosoma Cruzi or Trypanosoma Brucei. Said composition includes benznidazole and amphotericin BN-(L)-Histidinamide of formula (I). Una composición farmacéutica para el tratamiento de...

Full description

Saved in:
Bibliographic Details
Main Authors ESPINOZA GUTIÉRREZ Bertha Josefina, ORTEGA BLAKE Iván, MARTÍNEZ MARTÍNEZ Ignacio, LOPEZ ORTIZ Manuel, FERNANDEZ ZERTUCHE Mario, RODRIGUEZ LÓPEZ Yaneth Anahi, REGLA CONTRERAS José Ignacio, RODRIGUEZ FRAGOSO María De Lourdes
Format Patent
LanguageEnglish
Spanish
Published 02.03.2022
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a pharmaceutical composition for treating trypanosomiasis or infections caused by Trypanosoma Cruzi or Trypanosoma Brucei. Said composition includes benznidazole and amphotericin BN-(L)-Histidinamide of formula (I). Una composición farmacéutica para el tratamiento de tripanosomiasis o infecciones causada por Trypanosoma cruzi o Trypanosoma brucei, la composición farmacéutica incluye benznidazol y N-(L)-Histidinamida de anfotericina B de la fórmula (I): (ver fotmula).
Bibliography:Application Number: MX20190007278